1. | Chmielewski M, Hahn O, Rappl G, Nowak M, Schmidt-Wolf IH, Hombach AA, et al. T cells that target carcinoembryonic antigen eradicate orthotopic pancreatic carcinomas without inducing autoimmune colitis in mice. Gastroenterology. 2012;143:1095-107. (ELISA - Serum) | 2. | Zhang X, Wu C, Song J, Götte M, Sorokin L. Syndecan-1, a cell surface proteoglycan, negatively regulates initial leukocyte recruitment to the brain across the choroid plexus in murine experimental autoimmune encephalomyelitis. J Immunol. 2013;191:4551-61. (ELISA - Serum) | 3. | Patton DT, Plumb AW, Redpath SA, Osborne LC, Perona-Wright G, Abraham N. The development and survival but not function of follicular B cells is dependent on IL-7Rα Tyr449 signaling. PLoS One. 2014;9(2):e88771. (ELISA - Serum) | 4. | Chen A, Geng Y, Ke H, Constant L, Yan Z, Pan Y, et al. Cutting edge: Dexamethasone potentiates the responses of both regulatory T cells and B-1 cells to antigen immunization in the ApoE-/- mouse model of atherosclerosis. J Immunol. 2014;193:35-9. (ELISA - Serum) | 5. | Hartweger H, Schweighoffer E, Davidson S, Peirce MJ, Wack A, Tybulewicz VL. Themis2 is not required for B cell development, activation, and antibody responses. J Immunol. 2014;193:700-7. (ELISA - Serum) | 6. | Li X, Liang Y, LeBlanc M, Benner C, Zheng Y. Function of a Foxp3 cis-element in protecting regulatory T cell identity. Cell. 2014;158:734-48. (ELISA - Serum) | 7. | Ray A, Yuan C, Miller NM, Mei H, Dittel BN. 2B4 is dispensable for T-dependent B cell immune responses, but its deficiency leads to enhanced T-independent responses due to an increase in peritoneal cavity B1b cells. PLoS One. 2015;10(8):e0137314. (ELISA - Serum) | 8. | Kabat AM, Harrison OJ, Riffelmacher T, Moghaddam AE, Pearson CF, Laing A, et al. The autophagy gene Atg16l1 differentially regulates Treg and TH2 cells to control intestinal inflammation. Elife. 2016;5:e12444. (ELISA - Serum) |
|